Navigation Links
Misonix Terminates Distribution Agreement With Aesculap
Date:12/12/2012

FARMINGDALE, N.Y., Dec. 12, 2012 /PRNewswire/ -- Misonix, Inc. (NasdaqGM: MSON), an international surgical device company that designs, manufactures and markets innovative therapeutic ultrasonic products for spine surgery, skull-based surgery, neurosurgery, wound debridement, cosmetic surgery, laparoscopic surgery and other surgical applications, has announced the termination of its distribution agreement with Aesculap, Inc., for the Misonix BoneScalpel™ Ultrasonic Bone Cutting System.

Since January 2011, Aesculap has been a non-exclusive, private label distributor of the BoneScalpel in the United States, for clinical applications in spine surgery and cranial surgery.  Under the non-exclusive distribution agreement, Aesculap retains the right to sell BoneScalpel disposables to certain, limited hospital accounts, post termination, which are covered by binding supply agreements for varying periods of time, but not to exceed 3 years.  An additional aspect of the cancellation requires Misonix to purchase all hardware inventory in Aesculap's possession.  This inventory will feature prominently in the Company's plans to support its rapidly growing, proprietary sales organization with equipment for sales, demonstration and evaluation purposes.

Consistent with its business strategy, Misonix is committed to creating brand equity by selling its products under its own label via its own proprietary sales organization.  Misonix, to date, has appointed and trained upwards of 40 independent sales agencies, with more than 200 salespeople, to market its BoneScalpel product line to neurosurgeons, spine surgeons, orthopedic surgeons and cranio maxillo-facial surgeons, backed by its own sales & marketing management team.

The BoneScalpel is a novel ultrasonic osteotome used for safe, tissue-selective bone dissection that encourages en-bloc bone removal and refined osteotomies while sparing elastic soft tissue structures.  Most users report that the surgical field is relatively bloodless and clean.  Loss of viable bone is minimal and controllable.  The BoneScalpel has been used extensively for bone removal in the cervical, thoracic and lumbar spine, including deformity surgery, as well as a variety of 'skull based' surgical procedures. 

"We are grateful to Aesculap for their contributions, to date, to our sales success in the USA," said Michael A. McManus, Jr., President and Chief Executive Officer of Misonix.  "We look forward to maintaining the fine relationship established between our companies as we move through a transition period toward direct control of our destiny via our own direct distribution channel.  This decision by Misonix is a continuation of our strategy to be focused on our own unique products, to determine and manage our own strategic direction, to completely guide new product line extensions and to ensure complete dedication to the skills development of our BoneScalpel surgeons."

About MisonixMisonix, Inc. designs, develops, manufactures and markets therapeutic ultrasonic medical devices. Misonix's therapeutic ultrasonic platform is the basis for several innovative medical technologies. Addressing a combined market estimated to be in excess of $3 billion annually; Misonix's proprietary ultrasonic medical devices are used for wound debridement, cosmetic surgery, neurosurgery, laparoscopic surgery, and other surgical and medical applications. Additional information is available on the Company's Web site at www.misonix.com.

Safe Harbor StatementWith the exception of historical information contained in this press release, content herein may contain "forward looking statements" that are made pursuant to the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995. These statements are based on management's current expectations and are subject to uncertainty and changes in circumstances. Investors are cautioned that forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from the statements made. These factors include general economic conditions, delays and risks associated with the performance of contracts, risks associated with international sales and currency fluctuations, uncertainties as a result of research and development, acceptable results from clinical studies, including publication of results and patient/procedure data with varying levels of statistical relevancy, risks involved in introducing and marketing new products, potential acquisitions, consumer and industry acceptance, litigation and/or court proceedings, including the timing and monetary requirements of such activities, the timing of finding strategic partners and implementing such relationships, regulatory risks including approval of pending and/or contemplated 510(k) filings, the ability to achieve and maintain profitability in the Company's business lines, and other factors discussed in the Company's Annual Report on Form 10-K, subsequent Quarterly Reports on Form 10-Q and Current Reports on Form 8-K. The Company disclaims any obligation to update its forward-looking relationships.Investor Relations Contacts Misonix Contact:

Lytham Partners, LLCRichard Zaremba

Robert Blum, Joe Dorame, Joe Diaz631-694-9555

602-889-9700invest@misonix.com 

mson@lythampartners.com


'/>"/>
SOURCE Misonix, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Misonix Reports Strong Revenue Increases for the First Quarter of Fiscal 2013
2. Misonix Reports Strong Revenue Increases for the Three Months and Full-Year Ended June 30, 2012
3. Misonix Product Featured At Neurosurgery Congress
4. Misonix Adds 6 Spine Sales Agencies In The U.S.
5. Misonix Attends International Meeting On Advanced Spine Techniques (IMAST) - Introduces New Product
6. Misonix Inks New Distribution Agreement For Croatia And Slovenia
7. Misonix And Soelim Create New Distribution Alliance For South Korea
8. Misonix Participates In Cleveland Spine Review
9. Misonix Adds Industry Veteran To Management Team
10. Misonix Exhibits at Major Worldwide Spine Conference
11. Misonix And SIAD Healthcare Renew Distribution Agreement For Italy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2016)... N.J. , Feb. 9, 2016  Bluestar Silicones ... (LSR) product line for long-term implant applications and ... Medical Design & Manufacturing (MD&M) West Conference (Booth ... --> --> ... Silbione® Biomedical LSRs offer outstanding physical properties enabling ...
(Date:2/8/2016)... Respiratory Devices - Medical Devices Pipeline ... sector report, " Respiratory Devices - Medical Devices ... Respiratory Devices currently in pipeline stage. The ... with comparative analysis of the products at various ... involved in the pipeline product development. It also ...
(Date:2/8/2016)... 8, 2016 CBG Technologies, a U.S. ... Solvent Recycling Systems, specifically designed for precision parts ... new and existing vapor degreasers, parts washers and ... through continuous recycling and recovers 100% of the ... --> Precision parts manufacturers benefit from ...
Breaking Medicine Technology:
(Date:2/9/2016)... ... February 09, 2016 , ... Cirracore Enterprise ... enterprises move workloads to the cloud. Cirracore provides a secure VMware® vCloud ... traversing the Internet. Transformation Solutions (TSL Partners) provides a full range of ...
(Date:2/9/2016)... (PRWEB) , ... February 09, 2016 , ... ... specialty pharmacies, announces today the continuation of the ‘Pay It Forward’ program into ... prescription referral received at our specialty pharmacy. , “Since our Pay It ...
(Date:2/9/2016)... ... February 09, 2016 , ... On January 12, 2016 Paul ... appointment after they noticed their furnace not producing any heat. Shortly after entering the ... cracked heat exchanger was leaking dangerous levels of carbon monoxide into the home, at ...
(Date:2/9/2016)... ... February 09, 2016 , ... The ... Herberger’s and Younkers department stores, announced it has raised $176,000 to benefit the ... Holden Comprehensive Cancer Center at the University of Iowa, The Lynn Sage Cancer ...
(Date:2/9/2016)... ... 09, 2016 , ... ZipHearing.com is proud to ... hearing aids , increase industry transparency, and promote awareness of hearing solutions ... “For the average consumer, the hearing aid industry is esoteric and difficult to ...
Breaking Medicine News(10 mins):